Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5 Suppl
|
| pubmed:dateCreated |
1977-1-29
|
| pubmed:abstractText |
In patients receiving cadaveric kidneys and treated with antilymphocyte globulin (ALG) the one-year graft survival 59%. The corresponding figures with living related donors were 87% and 83%, respectively. Side effects of ALG, of which allergic reactions were the most common, prompted its withdrawal in 33% of the cases. All patients studied developed antibodies against horse gammaglobulin when tested with a passive haemagglutination inhibition technique. ALG seems to act upon the T-cells since the number of cells forming rosettes with sheep red blood cells was reduced.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0032-5473
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
67-71
|
| pubmed:dateRevised |
2009-10-22
|
| pubmed:meshHeading |
pubmed-meshheading:792849-Antilymphocyte Serum,
pubmed-meshheading:792849-Cadaver,
pubmed-meshheading:792849-Graft Survival,
pubmed-meshheading:792849-Hemagglutination Inhibition Tests,
pubmed-meshheading:792849-Humans,
pubmed-meshheading:792849-Kidney Transplantation,
pubmed-meshheading:792849-Time Factors,
pubmed-meshheading:792849-Transplantation, Homologous,
pubmed-meshheading:792849-Transplantation Immunology
|
| pubmed:year |
1976
|
| pubmed:articleTitle |
Experience with antilymphocyte globulin in 144 renal transplant recipients.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|